Get in touch
555-555-5555
mymail@mailservice.com
Spravato Intranasal Ketamine
If You Struggle With Treatment-Resistant Depression, There's A Different Choice To Turn To.
Spravato ® is the first FDA-approved nasal spray specifically for adults with
treatment-resistant depression. If you have tried two or more antidepressants and are still struggling with depressive symptoms, contact San Antonio Family Psychiatry about Spravato.
Spravato is a brand name for esketamine, which is an intranasal formulation of ketamine. Ketamine is a medication that has been used for many years as an anesthetic. In recent years, its has been used for in its potential therapeutic effects for treating certain mental health conditions.
Spravato was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of treatment-resistant depression in adults. It is specifically indicated for individuals who have not responded to antidepressant medications. The effects of Spravato are relatively rapid, with some patients experiencing improvement in symptoms within hours or days.
Spravato is typically reserved for individuals who have not responded well to other antidepressant medications. The administration of Spravato is done under the supervision of a San Antonio Family Psychiatry in a controlled setting.
San Antonio Family Psychiatry can provide more information about Spravato, evaluate whether it may be a suitable option for you, and guide you through the treatment process.
